Gts Securities LLC Dexcom Inc Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$64.0 - $116.06 $4.45 Million - $8.07 Million	69,500 Added 195.77%	105,000 $7.04 Million
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $2.99 Million - $3.81 Million	-27,100 Reduced 43.29%	35,500 $4.02 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $57,110 - $70,050	-500 Reduced 0.79%	62,600 $8.68 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $603,920 - $993,280	-8,000 Reduced 11.25%	63,100 $7.83 Million
Q3 2023 Nov 15, 2023	BUY	$86.06 - $137.93 $6.12 Million - $9.81 Million	71,100 New	71,100 $6.63 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.